منابع مشابه
Dysglycemia and cardiovascular risk.
1. Hoffmann R, von Bardeleben S, Kasprzak JD, et al. Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography: a multicenter comparison of methods. J Am Coll Cardiol 2006; 47:121–8. 2. Hoffmann R, von Bardeleben S, ten Cate F, et al. Assessment of systolic left ventricular function: a multi-...
متن کاملPrevalence of dysglycemia and other cardiovascular risk factors among the rural population of Oman.
T he prevalence of diabetes mellitus (DM) is increasing worldwide. In Sultanate of Oman 2 studies had been conducted in 1991 and 2000, which showed that the prevalence of DM were 10% and 12% respectively while that for impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) were 11% and 7% respectively. The objectives of the current study were to find out the prevalence of different...
متن کاملBasal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
BACKGROUND: The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested. METHODS: We randomly assigned 12,537 people (mean age, 63.5 years) with cardiovascular risk factors plus impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes to receive insulin glargine (with a...
متن کاملBasal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Methods We randomly assigned 12,537 people (mean age, 63.5 years) with cardiovascular risk factors plus impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes to receive insulin glargine (with a target fasting blood glucose level of ≤95 mg per deciliter [5.3 mmol per liter]) or standard care and to receive n–3 fatty acids or placebo with the use of a 2-by-2 factorial design. T...
متن کاملBasal insulin and cardiovascular and other outcomes in dysglycemia.
BACKGROUND The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested. METHODS We randomly assigned 12,537 people (mean age, 63.5 years) with cardiovascular risk factors plus impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes to receive insulin glargine (with a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2012
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2012.03.078